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Background-—Blood pressure (BP) trajectories derived from measurements repeated over years have low measurement error and
may improve cardiovascular disease prediction compared to single, average, and usual BP (single BP adjusted for regression
dilution). We characterized 10-year BP trajectories and examined their association with cardiovascular mortality, all-cause
mortality, and life years lost.
Methods and Results-—Data from 2 prospective and nearly extinct cohorts of middle-aged men—the Minnesota Business and
Professional Men Study (n=261) and the Zutphen Study (n=632)—were used. BP was measured annually during 1947–1957 in
Minnesota and 1960–1970 in Zutphen. BP trajectories were identiﬁed by latent mixture modeling. Cox proportional hazards and
linear regression models examined BP trajectories with cardiovascular mortality, all-cause mortality, and life years lost.
Associations were adjusted for age, serum cholesterol, smoking, and diabetes mellitus. Mean initial age was about 50 years in
both cohorts. After 10 years of BP measurements, men were followed until death on average 20 years later. All Minnesota men
and 98% of Zutphen men died. Four BP trajectories were identiﬁed, in which mean systolic BP increased by 5 to 49 mm Hg in
Minnesota and 5 to 20 mm Hg in Zutphen between age 50 and 60. The third systolic BP trajectories were associated with 2 to 4
times higher cardiovascular mortality risk, 2 times higher all-cause mortality risk, and 4 to 8 life years lost, compared to the ﬁrst
trajectory.
Conclusions-—Ten-year BP trajectories were the strongest predictors, among different BP measures, of cardiovascular mortality,
all-cause mortality, and life years lost in Minnesota. However, average BP was the strongest predictor in Zutphen. ( J Am Heart
Assoc. 2015;4:e001378 doi: 10.1161/JAHA.114.001378)
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T he relation between arterial blood pressure (BP) andcardiovascular disease (CVD) has been investigated in
many cohorts. The Prospective Studies Collaboration reported
a 1.5 to 2 times higher coronary heart disease mortality risk
per 20 mm Hg difference in systolic BP level.1 A previous
report from the Seven Countries Study indicated a 1.7 times
higher coronary heart disease mortality risk per 20 mm Hg
difference in systolic BP level.2 In both studies, BP was based
on resting BP obtained on a single occasion in midlife and
relative risks were adjusted for regression dilution.3
Compared to single BP assessment adjusted for regression
dilution, patterns of BP over time (ie, BP trajectories) may
have greater power in predicting CVD.4 In the Minnesota
Business and Professional Men Study and the Zutphen Study,
BP was recorded annually over a 10-year period.5,6 The
Minnesota Study started in 1947 and the Zutphen Study in
1960, a time in which only exceptionally high levels of BP
were treated.7,8 In 2002, the last Minnesota man died and by
2010, 98% of the Zutphen cohort had died. These “extinction”
cohorts provide a unique opportunity to study not only the
predictive value of BP trajectories in relation to CVD mortality
and all-cause mortality, but also in relation to life years lost.
The aim of the present study was to characterize trajectories
of systolic and diastolic BP based on annual resting BP
measurements over a 10-year period and to investigate the
association of these BP trajectories with CVD mortality, all-
cause mortality, and life years lost in 2 cohorts of middle-aged
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men followed to “extinction.” Moreover, we compared these
associations with those of single BP (deﬁned as BPmeasured at
baseline), average BP (deﬁned as the average of all available BP
levels during the 10-year period), and usual BP (deﬁned as single
BP adjusted for regression dilution) with CVD mortality, all-
cause mortality, and life years lost.
Methods
Design and Study Populations
An overview of the study design is given in Figure 1. We aimed to
replicate the results of the Minnesota cohort in those of the
Zutphen cohort. BP was measured annually in the periods 1947–
1971 in Minnesota and 1960–1970 in Zutphen. Therefore, a 10-
year period was chosen to model BP trajectories in both cohorts.
Minnesota Study
In 1947, business and professional men from the upper
socioeconomic class who resided in Minneapolis and St. Paul,
MN, were recruited for an epidemiologic program to cover
300 men. Detailed information about the study design is
described elsewhere.5 In total, 285 clinically healthy men,
aged 45 to 55 years, participated in the Minnesota Business
and Professional Men Study, subsequently referred to as the
Minnesota Study. In the ﬁrst decade, 15 men died and 4 men
had had myocardial infarction; we excluded these men from
analysis. No one had a medical history of stroke. In addition, 5
men were excluded for having <5 BP recordings during 1947–
1957, leaving 261 men for analysis.
Zutphen Study
In 1960, a longitudinal investigation on coronary heart disease
risk factors was begun among middle-aged men in the town of
Zutphen, The Netherlands. Out of 1088 randomly selected
men, aged 40 to 60 years, 878 men participated. In the ﬁrst
decade, 118 men died and 55 men had had myocardial
infarction or stroke; we excluded these men from analysis. In
addition, 73 men were excluded for having <5 BP recordings
during 1960–1970, leaving 632 men for analysis.
Oral informed consent was obtained, as was appropriate at
baseline in both cohorts, before the Helsinki Declaration was
developed.
Data Collection
Minnesota Study
Every year from 1947 through 1957, men were physically
examined at the Laboratory of Physiological Hygiene at the
University of Minnesota, Minneapolis, MN.5 Men came to the
Laboratory in the morning without breakfast and had avoided
strenuous activity after waking. BP was recorded with men in
the supine position with a mercury sphygmomanometer at the
beginning of the examination after at least 10 minutes of rest.
BP was recorded 3 times about 5 minutes apart. The mean of
these 3 recordings in systole and in the ﬁfth phase of diastole
was used for analysis. In total, 2738 recordings from 261 men
were available.
Height and weight were measured annually. Serum
cholesterol levels were determined with the Bloor method
from 1947 through 1953 and then converted to Abell–Kendall
values.5,9 Thereafter, Abell–Kendall values were used. Smoking
was assessed in 1954 by a questionnaire that included
questions that made it possible to reconstruct smoking habits
from 1947 onwards. Men were categorized into current former
or never smokers. Prevalence of diabetes mellitus was deter-
mined by self-reported physician diagnosis (annually) or fasting
glucose with a cutoff point of 7 mmol/L (in 1949 and 1952).
A 12-lead ECGwas taken every year and evaluated according to
the Minnesota Code.10
Figure 1. Overview of the study design. The age range at baseline is 45 to 55 years in 1947 in Minnesota
and 40 to 60 years in Zutphen. BP indicates blood pressure.
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Zutphen Study
Every year from 1960 through 1970, men were physically
examined according to the protocol of the Seven Countries
Study.11 With men in the supine position, BP was recorded
with a mercury sphygmomanometer at the end of the
examination after at least 5 minutes of rest. Two successive
BP recordings were made. The mean of these 2 recordings in
systole and in the ﬁfth phase of diastole was used. In total,
6616 recordings from 632 men were available.
Height and weight were measured annually. In 1960 and
1965, serum cholesterol levels were determined with the
Abell–Kendall method and in 1970 with the Zlatkis method12
that were converted to Abell–Kendall values.13 Smoking was
assessed by the Seven Countries Study questionnaire.11 Men
were categorized into current former or nonsmokers. Preva-
lence of diabetes mellitus was determined by self-reported
physician diagnosis in 1960, 1965, and 1970. A 12-lead ECG
was taken every year and evaluated according to the
Minnesota Code.10
Outcome Ascertainment
In both cohorts, men were followed to “extinction.” In
Minnesota, mortality follow-up continued until the last man
died in 2002. Mortality information was obtained from death
certiﬁcates, hospital records, the Minnesota Department of
Health, and the National Death Index. In Zutphen, mortality
follow-up continued until July 1, 2010, when 12 men aged 90
to 95 years were still alive. Mortality information was
obtained from the municipal population registry, hospital
disease registry, general practitioners, and Statistics Nether-
lands.
Causes of death were adjudicated by an expert in
cardiovascular epidemiology (A.M.), according to the
International Classiﬁcation of Diseases (ICD). In Minnesota,
CVD mortality included ICD-9 codes 401-459 and 798. In
Zutphen, CVD mortality included ICD-8 codes 400-458 and
795. In the present analysis, mortality follow-up started
10 years after baseline in both cohorts (Figure 1).
Statistical Analysis
Analyses were done separately for each cohort. Over a 10-
year period, systolic and diastolic BP trajectories were
identiﬁed by using latent mixture modeling within the PROC
TRAJ procedure in SAS.14 This procedure identiﬁes groups of
individuals with similar trajectories. We started with a
1-trajectory model and then ﬁtted those up to the optimal
number of trajectories by comparing the Bayesian Information
Criterion for each number of trajectories14 and by comparing
the number of men per trajectory. Each man was assigned to
a trajectory based on the likelihood of correctly classifying
men in trajectories (range of mean likelihood across
trajectories: 91% to 95%). Linear and quadratic terms were
considered and evaluated based on their signiﬁcance level,
starting with the highest polynomial. Age was used as
timescale for the trajectories. Because a small fraction of
men (<5% in both cohorts) was assigned to the fourth
systolic BP trajectories (SBP4), the present study focused on
the comparison of the third trajectories (SBP3) with the ﬁrst
trajectories (SBP1).
Cox proportional hazards analysis was used to investigate
the association of BP trajectories with risk of CVD and all-
cause mortality. Systolic or diastolic BP trajectories were
included as dummy variables in the model using the ﬁrst BP
trajectories (SBP1 and DBP1) as reference.
For all men who had died during follow-up, age at death
was calculated. Linear regression analysis was used to
investigate the association between BP trajectories and age
at death (which was normally distributed), resulting in the
estimated number of life years lost per trajectory compared to
mean age at death of the reference trajectory. BP trajectories
were included as dummy variables in the model using the ﬁrst
BP trajectories as reference. For the 12 men who were still
alive in Zutphen on July 1, 2010, their age in 2010 was used
as age at death. Using age plus 3 years (the life expectancy
for an average 90-to-95-year-old man in 2011) instead did not
change the results.
In addition to BP trajectories, Cox proportional hazards
analysis was used to investigate the association of single BP
(BP measured at baseline), average BP (average of all available
BP levels during the 10-year period), and usual BP (single BP
adjusted for regression dilution) with risk of CVD and all-cause
mortality. Linear regression analysis was used to investigate
the association of single, average, and usual BP with the
number of life years lost. Estimates were obtained for each
unit difference of 10, 25, and 50 mm Hg systolic BP and 10,
15, and 30 mm Hg diastolic BP. These units were selected
because they are similar to the differences in BP level
between the reference trajectory and other BP trajectories at
age 50 (the mean age at baseline). Average BP level was
deﬁned as the mean of all available BP levels during the
10-year period. We calculated the regression dilution ratio3
from 11 annual BP measurements over the 10-year period to
approximate the underestimate of the strength of the
association between usual BP and risk of CVD mortality,
all-cause mortality, and number of life years lost. The Akaike
Information Criterion of proportional hazards models (single
BP, average BP, and BP trajectories) were compared to
investigate the best model ﬁt.
Prediction of CVD mortality, all-cause mortality, and the
number of life years lost by BP trajectories was compared
between the 2 cohorts by calculating Z-scores and
corresponding P values. All associations were adjusted for
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age, serum cholesterol, smoking status, and diabetes mellitus
at baseline. Analyses were performed for both cohorts using
SAS version 9.2 (SAS Institute, Inc). A 2-sided P value of
<0.05 was considered statistically signiﬁcant.
Results
Initial mean age was 49.4 years in both cohorts (Table 1).
Mean BP level at baseline was 17/16 mm Hg lower in
Minnesota than in Zutphen. During 10 years, mean BP level
increased by 11/9 mm Hg in Minnesota and 5/0 mm Hg in
Zutphen. Mean body mass index was about 25 kg/m2 in both
cohorts at baseline and 10 years later. At baseline, mean
serum cholesterol level was 23 mg/dL higher in Zutphen,
compared to Minnesota, but levels were similar after
10 years. In Minnesota, fewer men were smokers than in
Zutphen. In both cohorts, few men were diabetic (<2%).
Four trajectories of systolic BP (SBP1 to SBP4) and
diastolic BP (DBP1 to DBP4) were identiﬁed in both cohorts
(Figure 2). Trajectories consisted of increasing BP levels
fanning out with age, that is, BP increased more rapidly in
men with higher initial BP levels. Mean systolic BP of the 4
trajectories increased by 5 to 49 mm Hg in Minnesota and 5
to 20 in Zutphen from age 50 to 60. For diastolic BP, these
10-year increases were 6 to 26 mm Hg in Minnesota and 2 to
12 mm Hg in Zutphen.
During a mean (SD) follow-up of 20.910.0 years, all
Minnesota men had died, of whom 137 (52.5%) died from
CVD. During a mean follow-up of 18.89.6 years, 623
Zutphen men had died (98.1%), of whom 282 (44.6%) died
from CVD. In both cohorts, CVD mortality rate was 25 per
1000 person-years and all-cause mortality rate was 50 per
1000 person-years. Mean age at death was 79.79.5 years
in Minnesota and 78.38.8 years in Zutphen.
Systolic BP was directly associated with CVD mortality
(Tables 2 and 3). This association was more pronounced in
Minnesota than in Zutphen. After adjustment, the third
systolic BP trajectory, SBP3, was associated with a CVD
mortality risk ratio of 3.8 (95% CI: 2.2 to 6.6) in Minnesota
and 2.1 (95% CI: 1.5 to 2.9) in Zutphen, compared to the ﬁrst
trajectory (Table 2). For SBP3, hazard ratios were signiﬁcantly
higher in Minnesota than in Zutphen (P=0.03) (Table 4). Each
unit difference of 25 mm Hg systolic BP was associated with
a CVD mortality risk ranging from 1.5 for single BP to 1.6 for
usual BP in Minnesota and from 1.3 for single BP to 1.7 for
average BP in Zutphen (Table 3). Similar patterns were found
for diastolic BP. In addition to CVD mortality, systolic BP was
directly associated with all-cause mortality (Tables 5 and 6).
BP trajectories were the strongest predictors of CVD and all-
cause mortality in Minnesota, whereas in Zutphen, average BP
was the strongest predictor (Table 7).
Systolic BP was directly associated with life years lost
(Tables 8 and 9). This association was more pronounced in
Minnesota than in Zutphen. After adjustment, the number of
life years lost associated with SBP3 was 8.1 (95% CI: 4.4 to
11.8) years in Minnesota and 3.7 (95% CI: 1.8 to 5.6) years in
Zutphen (Table 8). For SBP3, the number of life years lost
were signiﬁcantly higher in Minnesota than in Zutphen
(P=0.01) (Table 3). The number of life years lost associated
with each 25 mm Hg difference in systolic BP ranged from
Table 1. Characteristics of Men Participating in the Minnesota Study and the Zutphen Study at the First and Last Year of the BP
Trajectory
Minnesota Study Zutphen Study
1947 1957 1960 1970
N 261 231 632 568
Age, y 49.4 (2.8) 59.4 (2.8) 49.4 (5.4) 59.5 (5.4)
Height, cm 176.0 (6.2) 175.8 (6.3) 173.7 (6.6) 173.8 (6.6)
Weight, kg 76.3 (12.1) 78.1 (11.5)* 72.6 (9.5) 76.0 (9.5)†
BMI, kg/m2 24.6 (3.6) 25.3 (3.4)* 24.0 (2.7) 25.1 (2.7)†
Systolic BP, mm Hg 124.1 (15.4)‡ 134.8 (22.2) 141.4 (18.5)§ 146.1 (20.2)‖
Diastolic BP, mm Hg 73.0 (10.9)‡ 81.6 (11.6) 89.0 (11.8)¶ 88.9 (11.5)‖
Serum cholesterol, mg/dL 209.4 (33.6)‡ 234.4 (38.5)* 232.7 (43.6)** 237.6 (42.4)
Current smoking, N (%) 147 (56.3%)‡‡ 103 (44.6%)‡‡ 499 (74.3%) 304 (54.3%)††
Diabetes mellitus, N (%) 0 (0.0%) 4 (1.7%) 6 (0.9%) 10 (1.8%)
Values are means (SD) unless stated otherwise. BMI indicates body mass index; BP, blood pressure.
Data are available for *229 men, †565 men, ‡259 men, §629 men, ‖567 men, ¶628 men, **599 men, and ††560 men.
‡‡Smoking was assessed in 1954 by an extensive questionnaire that included questions about smoking history that made it possible to reconstruct the smoking habits in 1947. Smoking
habits in 1954 were used as a proxy for those in 1957.
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2.9 for single BP to 3.9 for average BP in Minnesota and from
1.7 for single BP to 2.9 for average BP in Zutphen (Table 9).
Similar patterns were found for diastolic BP.
Discussion
In 1 extinct cohort of American middle-aged men and 1
nearly extinct cohort of Dutch middle-aged men, 10-year BP
trajectories were identiﬁed that were strong predictors of
CVD mortality, all-cause mortality, and life years. Compared
to other BP measures, 10-year BP trajectories were the
strongest predictors of mortality in Minnesota. In Zutphen,
however, average BP was the strongest predictor of
mortality. The third systolic BP trajectory was associated
with 4 times greater CVD mortality risk in Minnesota and
2 times greater risk in Zutphen, compared to the ﬁrst
trajectory. In both cohorts, these trajectories were associ-
ated with a 2 times greater risk of all-cause mortality. The
number of life years lost between these trajectories was
8 years in Minnesota and 4 years in Zutphen.
In this study, mean initial BP level in Minnesota was lower
than in Zutphen. This ﬁnding was conﬁrmed by a study in
which BP levels in the Minnesota Study were compared to
those in other American cohorts.15 An explanation for these
lower BP levels may be that measured BP in Minnesota
was closer to basal BP levels because 3 consecutive
measurements of BP separated by 5 minutes each were
taken after a long period of rest. Moreover, the Minnesota
Study involved highly educated men who were selected for
health, whereas the Zutphen Study involved a random
population sample of Zutphen inhabitants.
Although BP levels were lower in Minnesota than in
Zutphen, we observed relatively similar BP trajectories in
both cohorts. In all 4 trajectories, BP levels increased more
rapidly in men with higher initial levels. In Minnesota, these
increases were more rapid than in Zutphen. For example,
from age 50 through 60, mean systolic BP of the
4 trajectories increased by 5 to 49 mm Hg in Minnesota
and 5 to 20 mm Hg in Zutphen. In the Framingham Heart
Study, 4 trajectories were identiﬁed in 890 men aged 30 to
84 years with a maximum of 15 BP measurements per
person. Systolic BP rose linearly by 5 to 23 mm Hg per
10 years within all 4 trajectories.16 These ﬁndings were
similar to those observed in Zutphen, but the associations
between trajectories and cardiovascular outcomes were not
investigated.
A B
C D
Figure 2. Trajectories of systolic (A, B) and diastolic (C, D) BP in 261 American men participating in the
Minnesota Study and 632 Dutch men participating in the Zutphen Study. DBP indicates diastolic blood
pressure; SBP, systolic blood pressure.
DOI: 10.1161/JAHA.114.001378 Journal of the American Heart Association 5
Blood Pressure Trajectories and CVD Mortality Tielemans et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 at Library Wageningen UR on May 21, 2015http://jaha.ahajournals.org/Downloaded from 
The CARDIA study recently demonstrated that higher BP
trajectories from young adulthood through middle age were
associated with an increased risk of coronary artery calciﬁ-
cation, a marker of subclinical atherosclerosis.4 In our study,
higher BP trajectories from middle age through old age were
associated with a higher risk of CVD mortality. Since the
Table 2. Hazard Ratios (95% CI) for Risk of CVD Mortality Per Trajectory of Systolic and Diastolic BP in the Minnesota Study and
the Zutphen Study
Minnesota Study (n=261) Zutphen Study (n=632)
N Unadjusted Age-adjusted*
Fully
adjusted†‡ N Unadjusted Age-adjusted* Fully adjusted†‡
N cases CVD
mortality (%)
137 (52.5%) 282 (44.6%)
Sum of
person-years
5448 11912
N cases/1000
person-years
25.1 23.7
Systolic BP trajectories
SBP1 119 Reference Reference Reference 195 Reference Reference Reference
SBP2 109 1.68 (1.16 to 2.43) 1.87 (1.28 to 2.72) 1.82 (1.25 to 2.66) 265 1.15 (0.86 to 1.54) 1.38 (1.03 to 1.86) 1.34 (1.00 to 1.81)
SBP3 29 3.11 (1.82 to 5.30) 3.91 (2.26 to 6.74) 3.80 (2.18 to 6.64) 142 1.56 (1.13 to 2.15) 2.13 (1.53 to 2.97) 2.05 (1.47 to 2.87)
SBP4 4 4.35 (1.35 to 14.04) 2.99 (0.92 to 9.75) 3.95 (1.17 to 13.38) 30 1.97 (1.15 to 3.39) 3.06 (1.76 to 5.33) 3.05 (1.74 to 5.33)
Diastolic BP trajectories
DBP1 113 Reference Reference Reference 240 Reference Reference Reference
DBP2 101 1.13 (0.78 to 1.65) 1.33 (0.90 to 1.95) 1.34 (0.90 to 1.98) 271 1.19 (0.91 to 1.56) 1.39 (1.06 to 1.82) 1.35 (1.02 to 1.78)
DBP3 42 1.63 (1.01 to 2.64) 2.09 (1.27 to 3.43) 2.10 (1.26 to 3.49) 92 1.16 (0.80 to 1.66) 1.69 (1.16 to 2.46) 1.66 (1.14 to 2.43)
DBP4 5 3.67 (1.32 to 10.17) 3.10 (1.11 to 8.65) 4.07 (1.42 to 11.63) 29 2.17 (1.31 to 3.61) 3.61 (2.13 to 6.10) 3.68 (2.16 to 6.26)
CVD indicates cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.
*Adjusted for age.
†Adjusted for age, serum cholesterol, smoking status, and diabetes mellitus.
‡Missing values for serum cholesterol at baseline were replaced by serum cholesterol levels measured at the consecutive year.
Table 3. Hazard Ratios* (95% CI) for CVD Mortality Risk Per Single BP Unit Difference† in the Minnesota Study and Zutphen Study
Minnesota Study (n=261) Zutphen Study (n=632)
Single BP‡ Average BP§ Usual BP‖ Single BP‡ Average BP§ Usual BP‖
Baseline systolic BP
Per 10 mm Hg 1.17 (1.06 to 1.28) 1.17 (1.08 to 1.27) 1.22 1.12 (1.06 to 1.19) 1.24 (1.15 to 1.34) 1.17
Per 25 mm Hg 1.47 (1.16 to 1.86) 1.49 (1.22 to 1.82) 1.62 1.34 (1.16 to 1.54) 1.72 (1.43 to 2.08) 1.50
Per 50 mm Hg 2.16 (1.35 to 3.45) 2.22 (1.49 to 3.33) 2.64 1.78 (1.34 to 2.38) 2.96 (2.03 to 4.32) 2.23
Baseline diastolic BP
Per 10 mm Hg 1.18 (1.02 to 1.37) 1.29 (1.10 to 1.50) 1.28 1.14 (1.03 to 1.26) 1.40 (1.20 to 1.62) 1.24
Per 15 mm Hg 1.28 (1.03 to 1.60) 1.46 (1.16 to 1.83) 1.44 1.21 (1.04 to 1.41) 1.65 (1.32 to 2.07) 1.37
Per 30 mm Hg 1.64 (1.06 to 2.55) 2.12 (2.12 to 3.37) 2.08 1.47 (1.08 to 1.99) 2.73 (1.74 to 4.27) 1.89
BP indicates blood pressure; CVD, cardiovascular disease.
*Adjusted for age, serum cholesterol, smoking status, and diabetes mellitus. Missing values for serum cholesterol at baseline were replaced by serum cholesterol levels measured at the
consecutive year.
†Differences in single BP level are similar to the differences in BP level between the reference trajectory (SBP1) and other BP trajectories at age 50, which is the mean age at baseline.
‡Deﬁned as BP level measured at baseline.
§Deﬁned as the average of all available BP levels during the 10-year period.
‖Deﬁned as single BP adjusted for regression dilution. Adjustment factors were 1.26 for systolic and 1.48 for diastolic BP in the Minnesota Study and 1.39 for systolic and 1.65 for diastolic
BP in the Zutphen Study.
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present study focuses on middle through old age, these
ﬁndings complement those of the younger CARDIA population.
Moreover, the association of BP trajectories with a mortality
end point, rather than a marker of CVD, was investigated in the
present study.
Our ﬁndings regarding life years lost are in line with those
of the Framingham Heart Study. In that study, normotensive
men were expected to live 1.7 years longer than prehyper-
tensive men and 5.1 years longer than hypertensive men.17
The second trajectory in our study, which is comparable to
Table 4. Comparison of Associations of Systolic BP Trajectories With CVD Mortality, All-Cause Mortality, and Life Years Lost
Between Minnesota and Zutphen
Minnesota Study Zutphen Study Z Score P Value
CVD mortality, HR (95% CI)
SBP2 1.82 (1.25 to 2.66) 1.34 (1.00 to 1.81) 1.27 0.10
SBP3 3.80 (2.18 to 6.64) 2.05 (1.47 to 2.87) 1.87 0.03
SBP4 3.95 (1.17 to 13.38) 3.05 (1.74 to 5.33) 0.40 0.34
All-cause mortality, HR (95% CI)
SBP2 1.44 (1.10 to 1.88) 1.12 (0.93 to 1.36) 1.47 0.07
SBP3 2.48 (1.62 to 3.79) 1.54 (1.23 to 1.93) 1.93 0.03
SBP4 2.45 (0.88 to 6.86) 2.44 (1.64 to 3.62) 0.01 0.50
Number of life years lost, years (95% CI)
SBP2 3.06 (0.68 to 5.43) 1.07 (0.53 to 2.67) 1.62 0.05
SBP3 8.10 (4.39 to 11.82) 3.68 (1.80 to 5.56) 2.32 0.01
SBP4 12.75 (3.74 to 21.77) 6.42 (3.11 to 9.74) 1.38 0.08
CVD indicates cardiovascular disease; HR, hazard ratio; SBP, systolic blood pressure.
Table 5. Hazard Ratios (95% CI) for Risk of All-Cause Mortality Per Trajectory of Systolic and Diastolic BP in the Minnesota Study
and the Zutphen Study
Minnesota Study (n=261) Zutphen Study (n=632)
N Unadjusted Age-adjusted* Fully adjusted†‡ N Unadjusted Age-adjusted* Fully adjusted†‡
N cases all-cause
mortality (%)
261 (100%) 620 (98.1%)
Sum of
person-years
5448 11912
N cases/1000
person-years
47.9 52.0
Systolic BP trajectories
SBP1 119 Reference Reference Reference 195 Reference Reference Reference
SBP2 109 1.34 (1.03 to 1.74) 1.48 (1.14 to 1.93) 1.44 (1.10 to 1.88) 265 0.93 (0.77 to 1.12) 1.12 (0.93 to 1.36) 1.12 (0.93 to 1.36)
SBP3 29 2.14 (1.42 to 3.23) 3.91 (1.73 to 4.01) 2.48 (1.62 to 3.79) 142 1.15 (0.92 to 1.43) 1.57 (1.25 to 1.96) 1.54 (1.23 to 1.93)
SBP4 4 2.71 (1.00 to 7.36) 1.91 (0.70 to 5.24) 2.45 (0.88 to 6.86) 30 1.47 (1.00 to 2.17) 2.32 (1.56 to 3.43) 2.44 (1.64 to 3.62)
Diastolic BP trajectories
DBP1 113 Reference Reference Reference 240 Reference Reference Reference
DBP2 101 1.08 (0.83 to 1.42) 1.26 (0.96 to 1.66) 1.24 (0.94 to 1.64) 271 0.91 (0.77 to 1.09) 1.05 (0.88 to 1.26) 1.04 (0.87 to 1.25)
DBP3 42 1.44 (1.01 to 2.06) 1.83 (1.27 to 2.64) 1.75 (1.21 to 2.55) 92 0.85 (0.67 to 1.09) 1.24 (0.96 to 1.60) 1.22 (0.95 to 1.58)
DBP4 5 2.42 (0.99 to 5.95) 2.05 (0.83 to 5.05) 2.55 (1.02 to 6.38) 29 1.36 (0.93 to 2.01) 2.24 (1.51 to 3.33) 2.38 (1.59 to 3.54)
DBP indicates diastolic blood pressure; SBP, systolic blood pressure.
*Adjusted for age.
†Adjusted for age, serum cholesterol, smoking status, and diabetes mellitus.
‡Missing values for serum cholesterol at baseline were replaced by serum cholesterol levels measured at the consecutive year.
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the prehypertensive group in the Framingham Heart Study,
was associated with 1.1 (Zutphen) to 3.1 (Minnesota) life
years lost compared with the ﬁrst trajectories. The third
trajectory, which is comparable to the hypertensive group,
was associated with 3.7 (Zutphen) to 8.1 (Minnesota) life
years lost. Although similar results were observed, it should
be noted that life expectancy was the outcome of the
Framingham Heart Study, whereas life years lost that are
based on the actual age at death was the outcome of the
present study.
Due to random-within person variation in BP, the strength
of the association between BP obtained on a single occasion
and mortality will be underestimated. By taking the average
BP or adjusting for regression dilution (usual BP), associations
with CVD mortality, all-cause mortality and life years lost
became stronger compared to single BP. Associations
regarding BP trajectories were about twice as strong as
compared to single BP. The number of life years lost
according to BP trajectories was twice as high in Minnesota
than in Zutphen. Moreover, we observed that BP trajectories
were stronger predictors of mortality than single, average, and
usual BP in Minnesota. In Zutphen, however, average BP was
the strongest predictor of mortality. BP was based on 3
recordings with longer time intervals in Minnesota and on 2
recordings with shorter time intervals in Zutphen. Therefore,
BP may be measured less accurately in Zutphen than in
Minnesota, which has led to less valid BP trajectories in
Zutphen. Another explanation could be that BP trajectories in
Zutphen are quite linear, which is also captured by average
BP. Therefore, the model with a long-term continuous BP
variable (average BP) was superior to the model with
categorical BP variables (BP trajectories) in terms of model
ﬁt. These ﬁndings indicate that measuring BP accurately is
crucial for estimating the association between BP and
mortality.
Cumulative BP levels over time (eg, patterns of BP) are not
taken into account in recommendations for management of
hypertension. In individuals younger than 60 years, the
current recommendation is to start pharmacologic treatment
Table 6. Hazard Ratios* (95% CI) for All-Cause Mortality Risk Per Single BP Unit Difference† in the Minnesota Study and Zutphen
Study
Minnesota Study (n=261) Zutphen Study (n=632)
Single BP‡ Average BP§ Usual BP‖ Single BP‡ Average BP§ Usual BP‖
Baseline systolic BP
Per 10 mm Hg 1.10 (1.02 to 1.18) 1.13 (1.06 to 1.20) 1.13 1.08 (1.04 to 1.13) 1.16 (1.10 to 1.23) 1.11
Per 25 mm Hg 1.26 (1.05 to 1.52) 1.34 (1.14 to 1.58) 1.34 1.21 (1.09 to 1.35) 1.46 (1.27 to 1.68) 1.30
Per 50 mm Hg 1.60 (1.11 to 2.30) 1.80 (1.31 to 2.48) 1.81 1.47 (1.19 to 1.82) 1.71 (1.24 to 2.37) 1.71
Baseline diastolic BP
Per 10 mm Hg 1.14 (1.02 to 1.27) 1.23 (1.09 to 1.38) 1.21 1.08 (1.01 to 1.16) 1.20 (1.08 to 1.33) 1.14
Per 15 mm Hg 1.21 (1.03 to 1.42) 1.36 (1.14 to 1.62) 1.33 1.12 (1.01 to 1.24) 1.31 (1.11 to 1.54) 1.21
Per 30 mm Hg 1.47 (1.06 to 2.03) 1.86 (1.31 to 2.64) 1.77 1.25 (1.01 to 1.55) 1.71 (1.24 to 2.37) 1.45
BP indicates blood pressure; CI, conﬁdence interval; CVD, cardiovascular disease; SBP, systolic blood pressure.
*Adjusted for age, serum cholesterol, smoking status, and diabetes mellitus. Missing values for serum cholesterol at baseline were replaced by serum cholesterol levels measured at the
consecutive year.
†Differences in single BP level are similar to the differences in BP level between the reference trajectory (SBP1) and other BP trajectories at age 50, which is the mean age at baseline.
‡Deﬁned as BP level measured at baseline.
§Deﬁned as the average of all available BP levels during the 10-year period.
‖Deﬁned as single BP adjusted for regression dilution. Adjustment factors were 1.26 for systolic and 1.48 for diastolic BP in the Minnesota Study and 1.39 for systolic and 1.65 for diastolic
BP in the Zutphen Study.
Table 7. Comparison of the Akaike Information Criterion*,
a Measure of the Model Fit, for Each Proportional Hazards
Model of Systolic BP†
Minnesota Study Zutphen Study
CVD mortality
Single systolic BP 1251 3126
Average systolic BP 1248 3111
Systolic BP trajectories 1239 3119
All-cause mortality
Single systolic BP 2379 6761
Average systolic BP 2374 6747
Systolic BP trajectories 2370 6750
*The lower the Akaike Information Criterion (AIC), the better the model ﬁt.
†The AIC was not obtained for usual blood pressure (BP), because for usual BP single BP
was adjusted for regression dilution.
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at BP levels of ≥140 mm Hg systolic or ≥90 mm Hg
diastolic.18 An individual’s BP pattern before reaching this
BP cut-off level is not included in these recommendations. Our
ﬁndings emphasize the importance of taking BP increases
during time into account. Increases in BP seem especially
important in the group that does not yet reach the treatment
cut-off level of 140/90 mm Hg. We observed that the ﬁrst
trajectories, in which systolic BP increased from 114 to
121 mm Hg in Minnesota and 125 to 130 mm Hg in Zutphen
from age 50 through 60, were the most favorable in terms of
Table 8. Life Years Lost (Years)* (95% CI) per Trajectory of Systolic and Diastolic BP in the Minnesota Study and the Zutphen Study
Minnesota Study (n=261) Zutphen Study (n=632)
N Unadjusted Age-adjusted† Fully adjusted‡§ N Unadjusted Age-adjusted† Fully adjusted‡§
Age at death, y 79.69.6 78.38.8
Systolic BP trajectories
SBP1 119 Reference Reference Reference 195 Reference Reference Reference
SBP2 109 3.29 (0.89 to 5.69) 3.35 (0.92 to 5.77) 3.06 (0.68 to 5.43) 265 1.32 (0.27 to 2.91) 0.97 (0.63 to 2.57) 1.07 (0.53 to 2.67)
SBP3 29 8.54 (4.79 to 12.29) 8.61 (4.84 to 12.39) 8.10 (4.39 to 11.82) 142 4.15 (2.29 to 6.01) 3.69 (1.82 to 5.56) 3.68 (1.80 to 5.56)
SBP4 4 11.88 (2.67 to 21.08) 11.96 (2.72 to 21.19) 12.75 (3.74 to 21.77) 30 6.69 (3.39 to 10.00) 6.07 (2.75 to 9.38) 6.42 (3.11 to 9.74)
Diastolic BP trajectories
DBP1 113 Reference Reference Reference 240 Reference Reference Reference
DBP2 101 2.28 (0.24 to 4.79) 2.45 (0.11 to 5.02) 2.28 (0.25 to 4.82) 271 0.84 (0.67 to 2.35) 0.48 (1.04 to 2.00) 0.55 (0.97 to 2.07)
DBP3 42 6.01 (2.69 to 9.34) 6.25 (2.86 to 9.65) 5.80 (2.46 to 9.14) 92 2.37 (0.28 to 4.45) 1.67 (0.45 to 3.79) 1.77 (0.35 to 3.89)
DBP4 5 11.08 (2.68 to 19.49) 11.40 (2.94 to 19.86) 11.61 (3.36 to 19.86) 29 6.68 (3.33 to 10.02) 5.84 (2.48 to 9.21) 6.37 (3.00 to 9.75)
DBP indicates diastolic blood pressure; SBP, systolic blood pressure.
*The number of life years lost is based on the age at death.
†Adjusted for age.
‡Adjusted for age, serum cholesterol, smoking status, and diabetes mellitus.
§Missing values for serum cholesterol at baseline were replaced by serum cholesterol levels measured at the consecutive year.
Table 9. Life Years Lost (Years)*† (95% CI) Per Single BP Unit Difference‡ in the Minnesota Study and Zutphen Study
Cohort
Minnesota Study (n=261) Zutphen Study (n=632)
Single BP§ Average BP‖ Usual BP¶ Single BP§ Average BP‖ Usual BP¶
Age at death, y 79.79.5 78.38.8
Baseline systolic BP
Per 10 mm Hg 1.16 (0.42 to 1.89) 1.54 (0.84 to 2.25) 1.46 0.66 (0.29 to 1.03) 1.16 (0.71 to 1.62) 0.92
Per 25 mm Hg 2.89 (1.05 to 4.73) 3.86 (2.10 to 5.62) 3.64 1.65 (0.73 to 2.57) 2.91 (1.78 to 4.04) 2.29
Per 50 mm Hg 5.79 (2.11 to 9.47) 7.71 (4.19 to 11.23) 7.30 3.30 (1.47 to 5.13) 5.82 (3.56 to 8.08) 4.59
Baseline diastolic BP
Per 10 mm Hg 1.58 (0.54 to 2.62) 2.64 (1.39 to 3.88) 2.34 0.68 (0.10 to 1.27) 1.51 (0.67 to 2.35) 1.12
Per 15 mm Hg 2.37 (0.80 to 3.93) 3.95 (2.09 to 5.82) 3.51 1.03 (0.15 to 1.90) 2.26 (1.01 to 3.52) 1.70
Per 30 mm Hg 4.73 (1.61 to 7.86) 7.91 (4.18 to 11.63) 7.00 2.05 (0.30 to 3.80) 4.53 (2.02 to 7.04) 3.38
BP indicates blood pressure; SBP, systolic blood pressure.
*The number of life years lost are based on the age at death.
†Adjusted for age, serum cholesterol, smoking status, and diabetes mellitus. Missing values for serum cholesterol at baseline were replaced by serum cholesterol levels measured at the
consecutive year.
‡Differences in single BP level are similar to the differences in BP level between the reference trajectory (SBP1) and other BP trajectories at age 50, which is the mean age at baseline.
§Deﬁned as BP level measured at baseline.
‖Deﬁned as the average of all available BP levels during the 10-year period.
¶Deﬁned as single BP adjusted for regression dilution. Adjustment factors were 1.26 for systolic and 1.48 for diastolic BP in the Minnesota Study and 1.39 for systolic and 1.65 for diastolic
BP in the Zutphen Study.
DOI: 10.1161/JAHA.114.001378 Journal of the American Heart Association 9
Blood Pressure Trajectories and CVD Mortality Tielemans et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 at Library Wageningen UR on May 21, 2015http://jaha.ahajournals.org/Downloaded from 
life years lost and risk of CVD and all-cause mortality.
Trajectories starting at a systolic BP level of 127 mm Hg in
Minnesota and 137 mm Hg in Zutphen at age 50 and
increasing with 10 mm Hg until age 60 were associated with
a 30% to 80% greater risk of CVD mortality, a 10% to 40%
greater risk of all-cause mortality and 1.1 to 3.1 life years lost,
compared with the ﬁrst trajectories. These ﬁndings suggest
that regularly monitoring BP of middle-aged men who have a
BP level between 130 to 140 mm Hg is important, as these
men are usually not treated but already have an increased risk
of CVD mortality. Monitoring BP in this group provides the
opportunity to detect hypertension and prevent CVD
earlier in life. Moreover, our ﬁndings show that average BP
is superior to single BP in terms of mortality prediction. For
clinical settings, this implies that a BP level based on
multiple annual BP recordings is a stronger predictor than a
BP level based on a few recordings at a single moment in
time.
A major strength of the present study is that detailed data
on BP during a long follow-up period were collected in both
cohorts. Almost everyone had died at the end of follow-up,
which enabled us to investigate the association of BP
trajectories with life years lost. A mean of 10 (out of 11) BP
measurements per person was included to characterize
10-year BP trajectories, which indicates that the majority of
men had complete BP data. Because cohorts were initiated in
a time when only very high levels of BP were treated, it is
unlikely that the observed associations are confounded by
antihypertensive medication. A drawback of the present study
is that the characterization of BP trajectories is complex. It is
too time-consuming to use BP trajectories as a predictive tool
in clinical settings. However, our ﬁndings on average BP and
mortality emphasize the importance of repeated BP
measurements from middle into old age, which is relevant
for clinicians. Another drawback is the small number of
participants. Few men were assigned to the fourth BP
trajectories, which warrants cautious interpretation for these
speciﬁc ﬁndings. It should be noted that the Minnesota men
were all from the upper socioeconomic class in the metro-
politan area of Minneapolis, St. Paul, which could limit the
generalizability of these ﬁndings. However, we observed
similar ﬁndings in the population-based Zutphen Study, which
included more men with large differences in socioeconomic
class.
Perspectives
In 2 cohorts of American and Dutch middle-aged men, 4 10-
year BP trajectories were characterized. BP trajectories were
stronger predictors of CVD mortality, all-cause mortality, and
life years lost than single, average, and usual BP in
Minnesota, but not in Zutphen. In general, we observed
similar associations within these cohorts, emphasizing the
replication of the results of 1 cohort in the other. To our
knowledge, this is the ﬁrst study that investigated the
association of BP trajectories with CVD mortality, all-cause
mortality, and life years lost. The novel approach of using data
from cohorts in which participants were physically examined
and followed to “extinction” provided a unique opportunity to
study the association of risk factors in relation to cardiovas-
cular health and life years lost.
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